{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:09:57Z","timestamp":1793315397890,"version":"4.5.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.xphs.2025.103749","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T01:53:54Z","timestamp":1743040434000},"page":"103749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Navigating ICH Q2(R2) compliance in analytical method validation: A gap analysis toolkit to streamline risk assessment and change management"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0019-5939","authenticated-orcid":false,"given":"Brianna","family":"Cassidy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4566-2234","authenticated-orcid":false,"given":"Timothy","family":"Bloomingdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Carmody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2025.103749_bib0001","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH Q2(R2) Validation of Analytical Procedures (2023). Accessed November 20, 2024. https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q2%28R2%29_Guideline_2023_1130.pdf"},{"key":"10.1016\/j.xphs.2025.103749_bib0002","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH Q14 Analytical Procedure Development (2023). Accessed November 20, 2024. https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q14_Guideline_2023_1116_1.pdf"},{"key":"10.1016\/j.xphs.2025.103749_bib0003","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. Final IWG Concept Paper Q2(R2) and Q14: Q2(R2) (2023). Accessed November 20, 2024. https:\/\/database.ich.org\/sites\/default\/files\/Q2R2-Q14_EWG_Concept_Paper.pdf"},{"key":"10.1016\/j.xphs.2025.103749_bib0004","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH guideline implementation: search for the status of implementation of ICH guidelines by ICH members. Accessed November 2021, 2024. https:\/\/ich.org\/page\/ich-guideline-implementation"},{"key":"10.1016\/j.xphs.2025.103749_bib0005","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH Q2(R2) and Q14 Step 4 Presentation (2023). Accessed November 20, 2024. https:\/\/database.ich.org\/sites\/default\/files\/Q2_Q14%20ICH_Step_4_Presentation_2023_1106_0.pdf"},{"key":"10.1016\/j.xphs.2025.103749_bib0006","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH Q2(R2)\/Q14 IWG Work Plan (2024). Accessed November 20, 2024. https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q2%28R2%29-Q14_IWG_WorkPlan_2024_0730.pdf"},{"key":"10.1016\/j.xphs.2025.103749_bib0007","unstructured":"Food and Drug Administration. FDA ICH Q2(R2) validation of analytical procedures; guidance for industry; final guidance (2024). Accessed December 12, 2024. https:\/\/www.regulations.gov\/commenton\/FDA-2022-D-1503-0021"},{"key":"10.1016\/j.xphs.2025.103749_bib0008","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH Q7 Good Manufacturing Practice Guide For Active Pharmaceutical Ingredients (2000). Accessed November 20, 2024. https:\/\/database.ich.org\/sites\/default\/files\/Q7%20Guideline.pdf"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925002072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925002072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:31:29Z","timestamp":1762209089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925002072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0022354925002072"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103749","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Navigating ICH Q2(R2) compliance in analytical method validation: A gap analysis toolkit to streamline risk assessment and change management","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103749"}}